Sometimes when I think of the human brain,the theme from"Star Trek"starts playing in my own head.It's the music of great unknowns—and in certain ways the human brain,with more connections between its cells than there are galaxies in ...
Tags: human brain, Brain Research
An international team of scientists led by National Institutes of Health researchers has traced the likely origin of the enzyme needed to manufacture the hormone melatonin to roughly 500 million years ago. Their work indicates that this ...
Tags: National Institutes of Health, origin of the enzyme, hormone melatonin
A recent study led by researchers from the Amyloidosis Center at Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) demonstrates that diflunisal, a generic anti-inflammatory drug, successfully reduced neurological ...
Tags: diflunisal, anti-inflammatory drug, transthyretin amyloidosis, arthritis
The U.S. National Institutes of Health is teaming up with the National Football League on research into the long-term effects of repeated head injuries and improving concussion diagnosis. The projects will be supported largely through a ...
Tags: U.S.National Institutes of Health, National Football League
Health R&D Spending Moves Slowly Upward, Driven by Industry, Philanthropy and Voluntary Health Associations Federal R&D Funding Remains "Woefully Inadequate" to Address Health Threats and Global Competitiveness ?Highlights: ?Overall ...
After declining in FY10-11,health-related research and development(R&D)spending in the U.S.increased by$4.3 billion(3.5%)in FY11-12,according to Truth and Consequences:Health R&D Spending in the U.S.(FY11-12),the 10th edition from ...
Tags: Health R&D Spending, R&D of Health
Pfenex has received a subcontract from Leidos Holdings (LDOS) to support the development of an anthrax vaccine containing its recombinant protective antigen (rPA) and a novel, immune-enhancing adjuvant. The initial contract was awarded by ...
Tags: Pfenex, Anthrax Vaccine
Two Cedars-Sinai physician-researchers have been awarded grants totaling $4 million from the National Institutes of Health to study how the environment - both in the womb and in the hospital where the baby is born - can affect the newborn ...
Navidea Biopharmaceuticals will collaborate with the University of Alabama at Birmingham (UAB) on a clinical study that will assess the safety and activity of a radiolabeled, humanized monoclonal antibody from its RIGS (radio-immuno-guided ...
According to the National Institutes of Health (NIH), Alzheimer's disease (AD) -- which robs people of the ability to think, remember and reason -- is an irreversible, progressive disease that eventually destroys even the ability to carry ...
Signum Dermalogix, a biopharmaceutical company, has announced that the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded the company a Small Business Innovation Research (SBIR) Phase II grant totaling ...
Wireless micro-LED devices are allowing researchers to use optogenetics to uncover information about molecular and cellular events in the brain that underlie stress, addiction and depression. To better understand and one day provide ...
Tags: Mico-LEDs, Sheds Light
Corgenix Medical, a developer of diagnostic test kits, has filed pre-market notification with the US Food and Drug Administration under Section 510(k) of the US Federal Food, Drug and Cosmetic Act for its hyaluronic acid (HA) enzyme-linked ...
Tags: Corgenix Medical
Transgene has received a sub-award from Emergent BioSolutions (EBS) under its existing grant of $5m from the US National Institute of Allergy and Infectious Diseases (NIAID), part of the US National Institutes of Health (NIH), to advance ...
Tags: Transgene, NIH Funding
The European Medicines Agency has launched a new version of the European clinical trials database, EudraCT V9. This new version marks the initial step of a process through which summary clinical trial results will be made publicly ...